Use of nonpeptide antagonists to explore the physiological roles of neurotensin. Focus on brain neurotensin/dopamine interactions.
Rostene
W
W
INSERM U.339, Hôpital St. Antoine, Paris, France. rostene@idf.ext.jussieu.fr
Azzi
M
M
Boudin
H
H
Lepee
I
I
Souaze
F
F
Mendez-Ubach
M
M
Betancur
C
C
Gully
D
D
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects / Q000502:physiology; D001921:Brain / Q000187:drug effects / Q000254:growth & development / Q000502:physiology*; D004298:Dopamine / Q000502:physiology*; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D006801:Humans; D051379:Mice; D009496:Neurotensin / Q000037:antagonists & inhibitors* / Q000502:physiology*; D011720:Pyrazoles / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D018028:Receptors, Neurotensin / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology; D014018:Tissue Distribution
D011720:Pyrazoles; D011804:Quinolines; D012333:RNA, Messenger; D018028:Receptors, Neurotensin; C086487:SR 48527; C079087:SR 48692; D009496:Neurotensin; D004298:Dopamine